These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1281 related items for PubMed ID: 25267785

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. The role of serum anti-Müllerian hormone (AMH) in the hormonal diagnosis of polycystic ovary syndrome.
    Casadei L, Madrigale A, Puca F, Manicuti C, Emidi E, Piccione E, Dewailly D.
    Gynecol Endocrinol; 2013 Jun; 29(6):545-50. PubMed ID: 23506275
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Anti-Müllerian hormone as a diagnostic tool for PCOS under different diagnostic criteria in an unselected population.
    Bozdag G, Mumusoglu S, Coskun ZY, Yarali H, Yildiz BO.
    Reprod Biomed Online; 2019 Sep; 39(3):522-529. PubMed ID: 31182353
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Serum anti-Mullerian hormone as a surrogate for antral follicle count for definition of the polycystic ovary syndrome.
    Pigny P, Jonard S, Robert Y, Dewailly D.
    J Clin Endocrinol Metab; 2006 Mar; 91(3):941-5. PubMed ID: 16368745
    [Abstract] [Full Text] [Related]

  • 34. Discordance between serum anti-Müllerian hormone concentrations and antral follicle counts: not only technical issues.
    Alebic MŠ, Stojanovic N, Dewailly D.
    Hum Reprod; 2018 Jun 01; 33(6):1141-1148. PubMed ID: 29688494
    [Abstract] [Full Text] [Related]

  • 35. Elevated serum levels of anti-Müllerian hormone can be introduced as a new diagnostic marker for polycystic ovary syndrome.
    Sahmay S, Atakul N, Aydogan B, Aydin Y, Imamoglu M, Seyisoglu H.
    Acta Obstet Gynecol Scand; 2013 Dec 01; 92(12):1369-74. PubMed ID: 23980726
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Predictive markers for the FSH sensitivity of women with polycystic ovarian syndrome.
    Köninger A, Sauter L, Edimiris P, Kasimir-Bauer S, Kimmig R, Strowitzki T, Schmidt B.
    Hum Reprod; 2014 Mar 01; 29(3):518-24. PubMed ID: 24419495
    [Abstract] [Full Text] [Related]

  • 38. Anti-Müllerian hormone reflects the severity of polycystic ovary syndrome.
    Jacob SL, Field HP, Calder N, Picton HM, Balen AH, Barth JH.
    Clin Endocrinol (Oxf); 2017 Mar 01; 86(3):395-400. PubMed ID: 27805276
    [Abstract] [Full Text] [Related]

  • 39. Relation of antimullerian hormone with the clinical signs of hyperandrogenism and polycystic ovary morphology.
    Sahmay S, Aydın Y, Atakul N, Aydogan B, Kaleli S.
    Gynecol Endocrinol; 2014 Feb 01; 30(2):130-4. PubMed ID: 24328568
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 65.